Julie A. Daugherty, ARNP

Julie Daugherty practices at ENT and Allergy Associates of Florida in Boca Raton, Florida.

Julie Daugherty's NPI, 1730264961, was assigned on October 26, 2006. Julie Daugherty holds Florida license ARNP2887462.

Julie Daugherty's primary practice is ENT and Allergy Associates of Florida, at 900 NW 13th St, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 338-3267.

Julie Daugherty's primary practice is ENT and Allergy Associates of Florida in Boca Raton, Florida. Julie Daugherty is also affiliated with Bethesda Hospital East. The medical group on file is ENT & Allergy Associates of Florida. Dmand AI also links Julie Daugherty to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Julie Daugherty practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Julie Daugherty's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Julie Daugherty is licensed in Florida.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, ear eustachian tube disorders, ear infection, head wound, itchy rashes and sleep apnea among the conditions Julie Daugherty treats.

CMS data shows 3,893 Medicare services from Julie Daugherty across 16 procedure codes in 2024, for 893 Medicare patients. Medicare paid $147,528 for them. Every service was in an office.

CMS counts 893 Medicare patients who saw Julie Daugherty in 2024. The largest group is 75 to 84, with 424 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Julie Daugherty's median patient age at 72, with 54% women.

In 2024, Julie Daugherty wrote 1,174 Medicare Part D claims for 496 patients. 99% of them were for generic drugs. CMS names the drug for 1,044 of them, across 15 drugs with 11 or more claims each, at $19,240 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Julie Daugherty for performance year 2024, reported individually. Julie Daugherty accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 30 general payments to Julie Daugherty from 7 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 98% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $710.